Abstract:Neuronal excitatory synapses are primarily located on small dendritic protrusions called spines. During synaptic plasticity underlying learning and memory, Ca2+ influx through postsynaptic NMDA-type glutamate receptors (NMDARs) initiates signaling pathways that coordinate changes in dendritic spine structure and synaptic function. During long-term potentiation (LTP), high levels of NMDAR Ca2+ influx promote increases in both synaptic strength and dendritic spine size through activation of Ca2+-dependent protein kinases. In contrast, during long-term depression (LTD), low levels of NMDAR Ca2+ influx promote decreased synaptic strength and spine shrinkage and elimination through activation of the Ca2+-dependent protein phosphatase calcineurin (CaN), which is anchored at synapses via the scaffold protein A-kinase anchoring protein (AKAP)150. In Alzheimer's disease (AD) the pathological agent amyloid-β (Aβ) may impair learning and memory through biasing NMDAR Ca2+ signaling pathways toward LTD and spine elimination. By employing AKAP150 knock-in mice of both sexes with a mutation that disrupts CaN anchoring to AKAP150, we revealed that local, postsynaptic AKAP-CaN-LTD signaling was required for Aβ-mediated impairment of NMDAR synaptic Ca2+ influx, inhibition of LTP, and dendritic spine loss. Additionally, we found that Aβ acutely engages AKAP-CaN signaling through activation of G protein-coupled metabotropic glutamate receptor 1 (mGluR1) leading to dephosphorylation of NMDAR-GluN2B subunits, which decreases Ca2+ influx to favor LTD over LTP, and cofilin, which promotes F-actin severing to destabilize dendritic spines. These findings reveal a novel interplay between NMDAR and mGluR1 signaling that converges on AKAP-anchored CaN to coordinate dephosphorylation of postsynaptic substrates linked to multiple aspects of Aβ-mediated synaptic dysfunction.Significance Statement Understanding mechanisms of synaptic dysfunction in Alzheimer's disease (AD) is pivotal for therapeutic advances. Amyloid-β oligomers (Aβo), primary culprits in AD pathology, disrupt critical synaptic plasticity mechanisms, leading to enhanced LTD and synaptic loss. However, the underlying signaling pathways remain elusive. Calcineurin (CaN), localized by AKAP79/150 at synapses, plays a key role in LTD formation. Inhibition of CaN mitigates Aβo-induced synaptic deficits, implicating its involvement in AD pathology. Our study shows that AKAP-anchored CaN is critical in acute Aβo-mediated inhibition of NMDAR Ca2+ signaling and dendritic spine loss. Additionally, we identify mGluR1 as an upstream regulator of these Aβo-induced deficits, highlighting several potential therapeutic targets for AD-related synaptic pathology.

Novel crosstalk mechanisms between GluA3 and Epac2 in synaptic plasticity and memory in Alzheimer's disease

Emerging role of AMPA receptor subunit GluA1 in synaptic plasticity: Implications for Alzheimer's disease

Acetylation of AMPA Receptors Regulates Receptor Trafficking and Rescues Memory Deficits in Alzheimer's Disease

A Novel Conditional Genetic System Reveals That Increasing Neuronal Camp Enhances Memory and Retrieval

Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models

AMPA receptors in Alzheimer disease: Pathological changes and potential therapeutic targets

The Specific Mechanism of TREM2 Regulation of Synaptic Clearance in Alzheimer's Disease

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

Targeting epigenetic mechanisms in amyloid-β-mediated Alzheimer's pathophysiology: unveiling therapeutic potential

Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.

Dysfunction of NMDA receptors in Alzheimer’s disease

Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.

The role of N-methyl-D-aspartate glutamate receptors in Alzheimer's disease: from pathophysiology to therapeutic approaches

Inhibition of AMP-Activated Protein Kinase Signaling Alleviates Impairments in Hippocampal Synaptic Plasticity Induced by Amyloid Β

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model

Role of Amyloid Β Protein Receptors in Mediating Synaptic Plasticity.

AMPA-ergic regulation of amyloid-β levels in an Alzheimer's disease mouse model

Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease

Molecular Mechanisms of AMPA Receptor Trafficking in the Nervous System

Amyloid-β causes NMDA receptor dysfunction and dendritic spine loss through mGluR1 and AKAP150-anchored calcineurin signaling

Selective disruption of synaptic NMDA receptors of the hippocampal trisynaptic circuit in Aβ pathology